Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer

Although breakthrough mucormycosis (BT-MCR) is known to develop on mold-active antifungals without Mucorales activity, it can also occur while on Mucorales-active antifungals. Herein, we retrospectively compared the characteristics and outcomes of patients with hematologic malignancies (HMs) or hema...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dierdre B. Axell-House, Sebastian Wurster, Ying Jiang, Andreas Kyvernitakis, Russell E. Lewis, Jeffrey J. Tarrand, Issam I. Raad, Dimitrios P. Kontoyiannis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-03-01
coleção:	Journal of Fungi
Assuntos:	mucormycosis mortality antifungal therapy breakthrough mold infection hematologic malignancy
Acesso em linha:	https://www.mdpi.com/2309-608X/7/3/217
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!